AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

Measles cases in the European region doubled to 127,350 in 2024, reaching the highest level in nearly three decades and ...

AstraZeneca has lined up a $1.2 billion takeover deal for Chinese biotech Gracell Biotechnologies, bolting a series of cell therapies for cancer and autoimmune diseases onto its pipeline.

After regulatory hold-ups in the US and Europe, Ipsen has claimed a confidence-boosting approval in Canada for palovarotene, a rare disease therapy acquired via its $1.3 billion takeover of ...

In recent years, the fields of Science, Technology, Engineering, and Mathematics (STEM) have been the cornerstone of innovation and progress. Yet, the STEM landscape has struggled with a ...

Sweden's Vicore Pharma has started a clinical trial of a digital therapeutic (DTx) intended to relieve anxiety in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and progressive ...

“Content developers realise they need to be flexible in their approach. The modular content workflow is a little bit more rigid and can lend itself to creating large volumes of content in a more ...

With growing regulatory pressure in Europe, including the EU's commitment to carbon neutrality by 2050, environmental sustainability is becoming an important consideration for pharmaceutical ...

Prenatal therapy for spinal muscular atrophy (SMA) with risdiplam has shown promise in a first-of-its-kind study led by Richard Finkel. Roche's Evrysdi has already shown profound benefits in ...

The role of medical affairs in the pharmaceutical industry is evolving rapidly, taking on greater strategic importance. Here, Christoph Bug, vice president of global medical at Veeva, and Pascal ...

Antibody-drug conjugates are coming back to the fore, with talks of multi-billion dollar buyouts and a rapidly growing number of approvals. Ben Hargreaves examines why the interest in the area is ...

Big data, artificial intelligence (AI), and machine learning (ML) are driving a technological revolution in healthcare. But with such rapid progress, understanding what these advancements mean in ...